| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-12,446 | -13,368 | -15,419 | - | - | - | |
Net loss | ||||||
- | - | - | -19,166 | -17,352 | -5,671 | |
Adjustments to reconcile net loss to net cash used in operating activities | ||||||
Depreciation and amortization | ||||||
921 | 730 | 669 | 656 | 624 | 573 | |
Bad debt expense | ||||||
- | - | - | - | - | 4 | |
Recovery of bad debt | ||||||
- | - | - | - | - | 8 | |
Deferred tax benefit | ||||||
- | - | - | - | -129 | 0 | |
Noncash interest expense | ||||||
13 | 133 | 185 | 4 | 1,598 | - | |
Noncash interest income | ||||||
21 | 0 | - | - | - | - | |
Noncash interest expense | ||||||
- | - | - | - | - | 84 | |
Stock compensation expense | ||||||
372 | 862 | 911 | 945 | 1,445 | 64 | |
Loss on sale of equipment | ||||||
-9 | 5 | 0 | -6 | 0 | - | |
Inventory obsolescence | ||||||
- | - | - | 113 | 0 | 21 | |
Change in fair value of derivative financial instruments | ||||||
- | - | - | - | 647 | 0 | |
Other non-cash items | ||||||
- | - | - | - | -24 | -14 | |
Change in fair value of warrant liability | ||||||
-0 | -8 | -144 | 0 | - | - | |
Impairment of right-of-use asset | ||||||
520 | 0 | - | - | - | - | |
Unamortized discount on bridge loan at repayment | ||||||
- | - | 85 | 0 | 0 | - | |
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
195 | -432 | 260 | -136 | 359 | 257 | |
Inventory | ||||||
-70 | 11 | -161 | -20 | 424 | 215 | |
Other assets | ||||||
-577 | -0 | 315 | -263 | -319 | -76 | |
Accounts payable | ||||||
-503 | 89 | -563 | -53 | 196 | 198 | |
Accrued compensation and other liabilities | ||||||
-818 | 77 | 399 | -163 | -1,508 | -99 | |
Deferred revenue | ||||||
-6 | -8 | -12 | - | - | - | |
Deferred revenue | ||||||
- | - | - | -13 | -288 | -170 | |
Net cash used in operating activities | ||||||
-11,505 | -11,073 | -14,303 | - | - | - | |
Cash flows from investing activities | ||||||
Note receivable | ||||||
2,500 | 0 | - | - | - | - | |
Net cash used in operating activities | ||||||
- | - | - | -17,250 | -14,278 | -5,385 | |
Cash acquired in business combinations | ||||||
- | - | - | - | 1,367 | 0 | |
Purchases of property and equipment | ||||||
31 | 147 | 276 | 123 | 185 | 39 | |
Proceeds from sale of equipment | ||||||
29 | 10 | 0 | - | - | - | |
Net cash used in investing activities | ||||||
-2,502 | -137 | -276 | - | - | - | |
Cash flows from financing activities | ||||||
Net cash provided by (used in) investing activities | ||||||
- | - | - | -123 | 1,181 | -39 | |
Proceeds from issuance of preferred stock, net of issuance costs | ||||||
- | - | - | - | - | 1,937 | |
Proceeds from issuance of common stock, net of issuance costs | ||||||
4,782 | 3,400 | 3,808 | 4,405 | 17,366 | 0 | |
Proceeds from issuance of units and exercises of pre-funded warrants, net of selling costs | ||||||
8,279 | 10,728 | - | - | - | - | |
Proceeds from issuance of convertible notes and warrants, net of issuance costs | ||||||
- | - | - | - | 1,388 | - | |
Proceeds from issuance of convertible notes, net of issuance costs | ||||||
- | - | - | - | - | 1,472 | |
Proceeds from issuance of promissory notes, net of issuance costs | ||||||
- | - | - | 204 | 1,741 | 1,488 | |
Proceeds from private offering of common stock, preferred stock and warrants, net of issuance costs | ||||||
- | - | - | 9,460 | 0 | - | |
Proceeds from issuance of units, net of selling costs | ||||||
- | - | 8,754 | 0 | - | - | |
Proceeds from exercise of stock options and warrants | ||||||
- | - | - | 23 | 2 | 0 | |
Proceeds from debt, net of issuance costs | ||||||
470 | 381 | 1,168 | 0 | - | - | |
Proceeds from exercise of stock options | ||||||
- | - | 76 | - | - | - | |
Payments on debt | ||||||
828 | 371 | 1,255 | 178 | 155 | 5 | |
Payments on finance lease obligations | ||||||
535 | 292 | - | - | - | - | |
Payments on capital lease obligations | ||||||
- | - | 205 | 251 | 175 | 105 | |
Net cash provided by financing activities | ||||||
12,168 | 13,845 | 12,348 | - | - | - | |
Effects of exchange rates on cash | ||||||
-3 | 12 | -37 | - | - | - | |
Deferred IPO issuance costs | ||||||
- | - | - | - | - | 13 | |
Net cash provided by financing activities | ||||||
- | - | - | 13,664 | 20,169 | 4,774 | |
Net increase in cash, cash equivalents and restricted cash | ||||||
-1,843 | 2,646 | -2,270 | - | - | - | |
Effects of exchange rates on cash | ||||||
- | - | - | 12 | -8 | 0 | |
Net decrease in cash and cash equivalents | ||||||
- | - | - | -3,696 | 7,064 | - | |
Net increase (decrease) in cash and cash equivalents | ||||||
- | - | - | - | - | -650 | |
Supplemental disclosure of cash flow information | ||||||
Cash paid for interest | ||||||
- | - | - | 58 | - | 32 | |
Cash paid for interest | ||||||
187 | 57 | 48 | - | 194 | - | |
Supplemental disclosures of noncash investing and financing activities: | ||||||
Shares issued to settle obligations | ||||||
0 | 272 | 133 | 0 | - | - | |
Right-of-use assets acquired through finance leases | ||||||
528 | 706 | - | - | - | - | |
Conversion of accounts payable to finance lease | ||||||
63 | 156 | - | - | - | - | |
Issuance of placement agent warrant | ||||||
- | - | - | 0 | - | - | |
Property and equipment acquired through capital lease | ||||||
- | - | 0 | - | 580 | 0 | |
Conversion of accounts payable to capital lease | ||||||
- | - | 0 | - | - | - | |
Deferred and accrued financing costs | ||||||
- | - | - | - | - | 282 | |
Exchange of demand note for convertible debt | ||||||
- | - | - | - | 300 | - | |
Unpaid deferred offering costs | ||||||
- | - | 48 | 0 | - | - | |
Common stock issued in business combination | ||||||
- | - | - | - | 2,584 | 0 | |
Conversion of convertible promissory notes to Series A preferred stock | ||||||
- | - | - | - | 3,000 | - | |
Conversion of series A preferred stock into common shares | ||||||
- | - | - | - | 8,183 | - | |
Exchange of demand notes | ||||||
- | - | - | - | 2,100 | - | |